LYNN SHA

3 federal lobbying filings, 2025 to 2026.

LYNN SHA is a registered lobbyist named on 3 federal lobbying filings, 2025 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

1 they have filed under, by filings.

Registrant	Filings	Reported
ABBOTT LABORATORIES	3	—

By year

Filings and what they reported, newest year first.

Year	Filings	Income	Expenses
2026	2	—	$2.6M
2025	1	—	$900K

Issues

The LDA issue codes the filings were filed under.

Code	Issue	Filings
`HCR`	Health Issues	3
`MMM`	Medicare/Medicaid	3
`TRD`	Trade (domestic/foreign)	3
`AGR`	Agriculture	2
`BUD`	Budget/Appropriations	2
`FOO`	Food Industry (safety, labeling, etc.)	2
`LAW`	Law Enforcement/Crime/Criminal Justice	2
`TAR`	Tariff (miscellaneous tariff bills)	2
`TAX`	Taxation/Internal Revenue Code	2
`CSP`	Consumer Issues/Safety/Products	1
`FIN`	Financial Institutions/Investments/Securities	1

Bills

The bills the filings name, by how many name them.

Bill	Title	Filings
H.R. 2300	To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and fo…	3
H.R. 4958	GRAS Act	2
H.R. 9817	Justice for Incarcerated Moms Act	2
S. 2426	Equitable Community Access to Pharmacist Services Act	2
S. 3387	One Fair Price Act of 2025	2
H.R. 1835	MERIT Act	1
H.R. 3164	Ensuring Community Access to Pharmacist Services Act	1
H.R. 5269	RESULTS Act	1
H.R. 7118	Genomic Answers for Children’s Health Act of 2026	1
H.R. 7966	Hospice CARE Act of 2026	1
S. 1000	A bill to establish an Ambassador-at-Large for Arctic Affairs.	1
S. 2003	Strengthening Benefit Plans Act of 2025	1
S. 2761	RESULTS Act	1
S. 4118	Hospice CARE Act of 2026	1

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

Client	Registrant	Period	Reported	Posted
ABBOTT LABORATORIES	ABBOTT LABORATORIES	2026 second_quarter	$1.2M	Jul 20, 2026
ABBOTT LABORATORIES	ABBOTT LABORATORIES	2026 first_quarter	$1.4M	Apr 20, 2026
ABBOTT LABORATORIES	ABBOTT LABORATORIES	2025 fourth_quarter	$900K	Jan 21, 2026

Lobbying Finance